-
Featured Authors
Jim’s Corner
Archive
- April 2013 (1)
- February 2013 (4)
- January 2013 (2)
- December 2012 (1)
- November 2012 (2)
- October 2012 (2)
- August 2012 (1)
- July 2012 (2)
- June 2012 (2)
- May 2012 (1)
- April 2012 (1)
- March 2012 (1)
- December 2011 (1)
- August 2011 (2)
- July 2011 (1)
- June 2011 (5)
- May 2011 (1)
- March 2011 (1)
- February 2011 (1)
- January 2011 (2)
- December 2010 (1)
- November 2010 (2)
- October 2010 (1)
- September 2010 (1)
- August 2010 (1)
- July 2010 (2)
- May 2010 (1)
- April 2010 (1)
- March 2010 (2)
- February 2010 (6)
- January 2010 (1)
- November 2009 (2)
- October 2009 (2)
- September 2009 (1)
- August 2009 (2)
- July 2009 (3)
- June 2009 (2)
- May 2009 (6)
- March 2009 (1)
Category Archives: Jim’s Corner
Twenty Years & Counting: Welcome to Chicago!
Welcome to the 2013 BIO International Convention. It is hard to believe, but this year BIO reaches a significant milestone as we celebrate 20 years of bringing innovation, opportunity and growth to an industry that heals, fuels and feeds the world. From a small beginning – less than 1,500 people attended the first BIO meeting in 1993 – our Convention has grown into the most influential biotech gathering in the world, attracting thousands of industry Read More >
Thoughts on the President’s State of the Union
I had several thoughts watching President Obama’s State of the Union Address tonight. First, we at BIO remain concerned about the possible impact that sequestration may have – specifically the potential impact it may have on human health. There are millions of patients – all hopeful that new treatments will become available soon. Our fear is that sequestration may impact the ability of those patients to access new treatments in a timely manner. That fear Read More >
Biotech Hall of Fame: Interview with Biotech’s First Investment Banker
Earlier this week, I had the opportunity to discuss biotech’s storied history with Fred Frank, one of the industry’s greatest luminaries, on what we can learn from the past to help shape the future. Fred Frank, formerly Vice Chairman of both Lehman Brothers Inc. and Peter J. Solomon Company, recently became Vice Chairman of Burrill & Company and Chairman of Burrill Securities, the broker dealer arm of Burrill & Company. He was the first life Read More >
A Call to Arms for Renewable Fuels
BIO President & CEO Jim Greenwood delivered remarks on the Renewable Fuel Standard and participated in a panel session on the Legacy of Bipartisan Support for Renewable Energy at ACORE’s National Renewable Energy Policy Forum, held on Capitol Hill: Good afternoon. It is good to be with ACORE again and to be part of your 10th annual policy forum. I had the pleasure of speaking at the RETECH 2012 conference in October. I said then Read More >
Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics
I was recently asked what the single biggest threat to the biotechnology industry is today. My answer was immediate – the biggest threat to biotech innovation is the unsustainable mismatch of spending and revenue in the U.S. federal budget. The enormous national debt and the huge annual budget deficits that feed it endanger America’s entire economic future – but the nation’s dire fiscal situation is particularly threatening to our industry. Part of the reason for Read More >
Jim's Corner
Leave a comment
Email This Post
Tags: 2013 BIO International Convention, BIO Events, BIO International Convention, budget deficit, debt ceiling, Events, FDA, federal budget, finance policy, Food and Drug Administration, Health Care, Medicaid, medicare, National Institutes of Health, NIH, simpson-bowles
Tags: 2013 BIO International Convention, BIO Events, BIO International Convention, budget deficit, debt ceiling, Events, FDA, federal budget, finance policy, Food and Drug Administration, Health Care, Medicaid, medicare, National Institutes of Health, NIH, simpson-bowles
